Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance

Abstract Background Abundant reports indicated that depression was often comorbid with type 2 diabetes and even metabolic syndrome. Considering they might share common biological origins, it was tentatively attributed to the chronic cytokine-mediated inflammatory response which was induced by dysreg...

Full description

Bibliographic Details
Main Authors: Wen-Jun Su, Wei Peng, Hong Gong, Yun-Zi Liu, Yi Zhang, Yong-Jie Lian, Zhi-Yong Cao, Ran Wu, Lin-Lin Liu, Bo Wang, Yun-Xia Wang, Chun-Lei Jiang
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-017-0985-4
_version_ 1818243450512867328
author Wen-Jun Su
Wei Peng
Hong Gong
Yun-Zi Liu
Yi Zhang
Yong-Jie Lian
Zhi-Yong Cao
Ran Wu
Lin-Lin Liu
Bo Wang
Yun-Xia Wang
Chun-Lei Jiang
author_facet Wen-Jun Su
Wei Peng
Hong Gong
Yun-Zi Liu
Yi Zhang
Yong-Jie Lian
Zhi-Yong Cao
Ran Wu
Lin-Lin Liu
Bo Wang
Yun-Xia Wang
Chun-Lei Jiang
author_sort Wen-Jun Su
collection DOAJ
description Abstract Background Abundant reports indicated that depression was often comorbid with type 2 diabetes and even metabolic syndrome. Considering they might share common biological origins, it was tentatively attributed to the chronic cytokine-mediated inflammatory response which was induced by dysregulation of HPA axis and overactivation of innate immunity. However, the exact mechanisms remain obscure. Herein, we mainly focused on the function of the NLRP3 inflammasome to investigate this issue. Methods Male C57BL/6 mice were subjected to 12 weeks of chronic unpredictable mild stress (CUMS), some of which were injected with glyburide or fluoxetine. After CUMS procedure, behavioral and metabolic tests were carried out. In order to evaluate the systemic inflammation associated with inflammasome activation, IL-1β and inflammasome components in hippocampi and pancreases, as well as corticosterone and IL-1β in serum were detected separately. Moreover, immunostaining was performed to assess morphologic characteristics of pancreases. Results In the present study, we found that 12 weeks’ chronic stress resulted in depressive-like behavior comorbid with insulin resistance. Furthermore, antidiabetic drug glyburide, an inhibitor of the NLRP3 inflammasome, was discovered to be effective in preventing the experimental comorbidity. In brief, it improved behavioral performance, ameliorated insulin intolerance as well as insulin signaling in the hippocampus possibly through inhibiting NLRP3 inflammasome activation by suppressing the expression of TXNIP. Conclusions All these evidence supported our hypothesis that chronic stress led to comorbidity of depressive-like behavior and insulin resistance via long-term mild inflammation. More importantly, based on the beneficial effects of blocking the activation of the NLRP3 inflammasome, we provided a potential therapeutic target for clinical comorbidity and a new strategy for management of both diabetes and depression.
first_indexed 2024-12-12T14:01:19Z
format Article
id doaj.art-021e5459c7d241fdbac3c726a06e1198
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-12T14:01:19Z
publishDate 2017-10-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-021e5459c7d241fdbac3c726a06e11982022-12-22T00:22:19ZengBMCJournal of Neuroinflammation1742-20942017-10-0114111210.1186/s12974-017-0985-4Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistanceWen-Jun Su0Wei Peng1Hong Gong2Yun-Zi Liu3Yi Zhang4Yong-Jie Lian5Zhi-Yong Cao6Ran Wu7Lin-Lin Liu8Bo Wang9Yun-Xia Wang10Chun-Lei Jiang11Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityDepartment of Psychiatry, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityLaboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical UniversityAbstract Background Abundant reports indicated that depression was often comorbid with type 2 diabetes and even metabolic syndrome. Considering they might share common biological origins, it was tentatively attributed to the chronic cytokine-mediated inflammatory response which was induced by dysregulation of HPA axis and overactivation of innate immunity. However, the exact mechanisms remain obscure. Herein, we mainly focused on the function of the NLRP3 inflammasome to investigate this issue. Methods Male C57BL/6 mice were subjected to 12 weeks of chronic unpredictable mild stress (CUMS), some of which were injected with glyburide or fluoxetine. After CUMS procedure, behavioral and metabolic tests were carried out. In order to evaluate the systemic inflammation associated with inflammasome activation, IL-1β and inflammasome components in hippocampi and pancreases, as well as corticosterone and IL-1β in serum were detected separately. Moreover, immunostaining was performed to assess morphologic characteristics of pancreases. Results In the present study, we found that 12 weeks’ chronic stress resulted in depressive-like behavior comorbid with insulin resistance. Furthermore, antidiabetic drug glyburide, an inhibitor of the NLRP3 inflammasome, was discovered to be effective in preventing the experimental comorbidity. In brief, it improved behavioral performance, ameliorated insulin intolerance as well as insulin signaling in the hippocampus possibly through inhibiting NLRP3 inflammasome activation by suppressing the expression of TXNIP. Conclusions All these evidence supported our hypothesis that chronic stress led to comorbidity of depressive-like behavior and insulin resistance via long-term mild inflammation. More importantly, based on the beneficial effects of blocking the activation of the NLRP3 inflammasome, we provided a potential therapeutic target for clinical comorbidity and a new strategy for management of both diabetes and depression.http://link.springer.com/article/10.1186/s12974-017-0985-4DepressionInsulin resistanceGlyburideNLRP3 inflammasomeStressInflammation
spellingShingle Wen-Jun Su
Wei Peng
Hong Gong
Yun-Zi Liu
Yi Zhang
Yong-Jie Lian
Zhi-Yong Cao
Ran Wu
Lin-Lin Liu
Bo Wang
Yun-Xia Wang
Chun-Lei Jiang
Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
Journal of Neuroinflammation
Depression
Insulin resistance
Glyburide
NLRP3 inflammasome
Stress
Inflammation
title Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
title_full Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
title_fullStr Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
title_full_unstemmed Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
title_short Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
title_sort antidiabetic drug glyburide modulates depressive like behavior comorbid with insulin resistance
topic Depression
Insulin resistance
Glyburide
NLRP3 inflammasome
Stress
Inflammation
url http://link.springer.com/article/10.1186/s12974-017-0985-4
work_keys_str_mv AT wenjunsu antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT weipeng antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT honggong antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT yunziliu antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT yizhang antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT yongjielian antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT zhiyongcao antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT ranwu antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT linlinliu antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT bowang antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT yunxiawang antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance
AT chunleijiang antidiabeticdrugglyburidemodulatesdepressivelikebehaviorcomorbidwithinsulinresistance